An In-Vitro lung model is a scientific construct designed to imitate the cellular, structural, and functional properties of the human lung in a controlled laboratory environment. These models enable researchers to investigate illness development, discover biomarkers, and assess treatment efficacy. They are useful tools for better understanding lung biology, developing therapies, and improving health outcomes.
Sizing and Forecast
The in vitro lung model market size has grown exponentially in recent years. It will grow from $0.37 billion in 2023 to $0.44 billion in 2024 at a compound annual growth rate (CAGR) of 21%. The growth in the historic period can be attributed to growing prevalence of respiratory diseases, increased focus on personalized medicine, growing interest in drug repurposing, emphasis on precision medicine approaches, growing awareness of environmental health risks.
The vitro lung model market size is expected to see exponential growth in the next few years. It will grow to $0.96 billion in 2028 at a compound annual growth rate (CAGR) of 21.1%. The growth in the forecast period can be attributed to drug development needs, rise in preclinical testing, increasing awareness of respiratory toxicology, focusing on regenerative medicine, growing environmental concerns, increasing geriatric populations. Major trends in the forecast period include increased demand for drug testing, advancements in 3D printing technology, advancements in organ-on-chip technology, integration of AI and machine learning, integration of sensors and monitoring devices, expansion of applications beyond pharmaceuticals, development of disease-specific models.
Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/in-vitro-lung-model-global-market-report
Segmentation & Regional Insights
The in-vitro lung model market covered in this report is segmented –
1) By Type: Two-Dimensional (2D) Model, Three-Dimensional (3D) Model
2) By Application: Drug Discovery And Toxicology Studies, Physiological Research, Three-Dimensional (3D) Model Development, Other Applications
3) By End-User: Academic Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
North America was the largest region in the in-vitro lung model market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on a free sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15837&type=smp
Major Driver Impacting Market Growth
The increase in clinical studies is expected to propel the growth of the in vitro lung model market going forward. Clinical trials refer to research studies that test how well new medical approaches work in people. The increase in clinical studies is driven by the growing need for advanced medical treatments, rising healthcare demands, and the pursuit of innovative solutions to complex health issues. In vitro lung models help in clinical trials by providing a controlled environment to study the effects of substances on lung tissue, aiding in drug testing, toxicity assessment, disease modeling, and understanding disease mechanisms. For instance, in January 2024, according to ClinicalTrials.gov, a US-based clinical trial registry, by the end of 2023, 477,230 clinical trials registered globally on ClinicalTrials.gov, an increase compared to 437,508 registered clinical trials in 2022. Therefore, the increase in clinical studies drives the in vitro lung model market.
Key Industry Players
Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper Laboratory Inc. , STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH
The in-vitro lung model market report table of contents includes:
1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 029
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
